Eli Lilly to Acquire Centessa to Expand Into Sleep Disorders – Merger Arbitrage Mondays
Centessa Pharmaceuticals plc (CNTA): $39.69 Market Cap: $5.34B Deal Value: $6.3B Eli Lilly (LLY) entered a merger agreement on March 31, 2026, to acquire sleep drug maker Centessa…
Written byAsif SuriaSource: InsideArbitrage
Centessa Pharmaceuticals plc (CNTA): $39.69 Market Cap: $5.34B Deal Value: $6.3B Eli Lilly (LLY) entered a merger agreement on March 31, 2026, to acquire sleep drug maker Centessa Pharmaceuticals in a deal valued at $6.3 billion, as the U.S.-based drugmaker seeks to broaden its focus beyond metabolic therapies and move into developing treatments for sleep disorders. UK-based